SafetyMargin.ioSafetyMargin.io
BlogWatchlistCompare
Compare Stocks › ABBV vs WRB

AbbVie Inc. (ABBV) vs W.R. Berkley Corporation (WRB): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. WRB is fairly valued at $73, with an intrinsic value of $76 and a margin of safety of 4%. Of the two, WRB has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
WRB
W.R. Berkley Corporation
$72.54

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
WRB
  • ★W.R. Berkley Corporation scores 99/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Free cash flow has grown at a 10.7% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Each dollar of retained earnings has created $1.38 of earning power — management is creating shareholder value.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
WRB
  • ⚠PEG ratio of 4.90 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠Altman Z-Score of 1.22 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
ABBV
WRB
Valuation
N/A
Free Cash Flow
$3.05B
N/A
FCF Yield
11.31%
70.89
Trailing P/E
14.93
15.41
Forward P/E
15.02
Quality & Moat
27.60%
ROIC
14.89%
N/A
ROE
20.21%
72.79%
Gross Margin
43.79%
0.41
PEG Ratio
4.90
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
-0.31
2.76%
Dividend Yield
0.55%
ABBV: 4Ties: 2WRB: 2
ABBVWRB

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

WRB

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
WRB
$2.28
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$3.18B
Δ Market Cap
+$7.25B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
WRB
4.0% Margin of Safety
Price is 4.0% below estimated fair value
Current Price: $72.54
Fair Value: $75.56
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

WRB

What growth rate is the market pricing in at $73?

+3.5%
Market-Implied Owner Earnings Growth
Standard FCF implies -4.0%

The market implies +3.5% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -4.0%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
WRB
99/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
WRB
-2.63
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
WRB
Insiders 26.4%Institutions 78.0%
No. of Institutional Holders1,257
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
WRB
0
Buys (3M)
19
Buys (12M)
Total value (12M): $665.29M
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$18.75M
@ $72.61 · 2026-03-03
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$21.49M
@ $71.65 · 2026-02-27
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$39.38M
@ $71.13 · 2026-02-25
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$35.74M
@ $70.70 · 2026-02-20
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$2.84M
@ $70.93 · 2026-02-13
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$6.83M
@ $69.68 · 2026-02-11
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$2.84M
@ $70.88 · 2026-02-06
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$21.45M
@ $68.05 · 2026-02-04
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$33.09M
@ $68.22 · 2026-01-30
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$69.30M
@ $67.35 · 2026-01-28
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$46.90M
@ $67.19 · 2026-01-23
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$42.61M
@ $67.64 · 2026-01-21
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$36.64M
@ $68.49 · 2026-01-16
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$55.62M
@ $68.58 · 2026-01-14
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$32.64M
@ $69.45 · 2026-01-09
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$47.42M
@ $69.61 · 2026-01-07
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$47.17M
@ $70.11 · 2026-01-02
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$62.04M
@ $70.53 · 2025-12-29
MITSUI SUMITOMO INSURANCE CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
$42.55M
@ $69.71 · 2025-12-22
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
WRB
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
WRB
FearGreed
😐Neutral(58/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
WRB
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (58)
View ABBV Full AnalysisView WRB Full Analysis

Frequently Asked Questions: ABBV vs WRB

Is AbbVie Inc. or W.R. Berkley Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, WRB trades at a 4.0% margin of safety (intrinsic value $76 vs. price $73), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

Which stock has a wider economic moat, AbbVie Inc. or W.R. Berkley Corporation?▼

WRB scores 99/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is W.R. Berkley Corporation in financial distress?▼

WRB's Altman Z-Score of 1.2 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or W.R. Berkley Corporation?▼

ABBV earns 27.6% ROIC versus WRB's 14.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or W.R. Berkley Corporation's?▼

WRB's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). WRB has raised its dividend for 3 consecutive years.